KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Supernus Pharmaceuticals (SUPN) Amortization of Deferred Charges (2016 - 2023)

Supernus Pharmaceuticals has reported Amortization of Deferred Charges over the past 13 years, most recently at $532000.0 for Q1 2023.

  • Quarterly Amortization of Deferred Charges rose 6.4% to $532000.0 in Q1 2023 from the year-ago period, while the trailing twelve-month figure was $532000.0 through Dec 2023, down 74.16% year-over-year, with the annual reading at $532000.0 for FY2023, 74.81% down from the prior year.
  • Amortization of Deferred Charges was $532000.0 for Q1 2023 at Supernus Pharmaceuticals, roughly flat from $530000.0 in the prior quarter.
  • Over five years, Amortization of Deferred Charges peaked at $4.5 million in Q4 2021 and troughed at $500000.0 in Q1 2022.
  • The 5-year median for Amortization of Deferred Charges is $4.0 million (2019), against an average of $3.1 million.
  • Year-over-year, Amortization of Deferred Charges skyrocketed 528.76% in 2019 and then tumbled 88.37% in 2022.
  • A 5-year view of Amortization of Deferred Charges shows it stood at $4.0 million in 2019, then increased by 5.03% to $4.2 million in 2020, then rose by 7.17% to $4.5 million in 2021, then tumbled by 88.22% to $530000.0 in 2022, then grew by 0.38% to $532000.0 in 2023.
  • Per Business Quant, the three most recent readings for SUPN's Amortization of Deferred Charges are $532000.0 (Q1 2023), $530000.0 (Q4 2022), and $529000.0 (Q3 2022).